COVID-19 Impact on Medical Coatings Market: Revenue Analyzed and Forecast Growth to 2025- Exclusive Report by MarketsandMarkets™
The growth of this market can be attributed to the rising income levels in emerging economies, a growing percentage of the geriatric population, and the increasing use of home healthcare facilities.
The global medical coatings market size is projected to grow from USD 6.0 billion in 2020 to USD 15.2 billion by 2025, at a CAGR of 20.5% during the forecast period. The major factors driving the market are the rising income levels in emerging economies, a growing percentage of the geriatric population, and the increasing use of home healthcare facilities.
The major players in the medical coatings market include DSM (Netherlands), Hydromer (US), Surmodics (US), Biocoat (US), AST Products (US), Covalon Technologies (Canada), Harland Medical Systems (US), Applied Medical Coatings (US), Freudenberg (US), and Merit Medical OEM (US). These players have adopted various growth strategies to expand their presence in the market further. New product launch, agreement & collaboration, merger & acquisition, partnership, and investment & expansion have been the leading strategies adopted by the major players in the last five years to strengthen their competitiveness and broaden their customer base in the global medical coatings market.
Get PDF Brochure for Research Insights at: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76047356
APAC is projected to lead the medical coatings market during the forecast period. The growing population, rising percentage of the geriatric population, augmenting healthcare investments, and increasing income levels in the region are the major drivers for the medical coatings market in the region. The healthcare industry in APAC has been experiencing positive transformations in the healthcare system in terms of healthcare infrastructure and public-private partnerships. These factors are also responsible for the highest CAGR of the market in the region.
Hydromer is the largest player operating in the medical coatings market. The company offers a wide range of medical coatings for various applications, such as stents, dental implants, orthopedic devices, tunneling catheter fixation, pacemaker fixation, ocular catheter fixation, and other medical device applications. The company has adopted partnership, agreement, and investment & expansion strategies to broaden its product portfolio and maintain its position in the market.
In November 2020, Hydromer partnered with N8 Medical for the supply of coatings to manufacture CeraShield endotracheal tubes. These tubes play a crucial role in the treatment of COVID-19 patients. This development exhibits active involvement of the company in the coatings market.
DSM is one of the largest producers of medical coatings in the world. The company offers a wide range of medical coatings. It has a portfolio that suits various medical device applications such as introducer sheaths, guidewires, access systems, guiding catheters, diagnostic catheters, balloon catheters, thrombectomy devices, aspiration catheters, neurovascular catheters, stent delivery systems, stent-graft delivery systems, heart valve delivery systems, foley catheters, and intermittent catheters. In recent years, DSM has adopted partnership as a key business strategy to strengthen its position in the market and maintain its leading position in the medical coatings market.
Get the Latest Version of the Report and ahead from Your Competitors: https://www.marketsandmarkets.com/RequestNewVersion.asp?id=76047356
In January 2016, DSM Biomedical partnered with Vention Medical, a global integrated solutions partner. The partnership offers integration of development, testing, and application of DSM’s ComfortCoat coating into the catheter manufacturing process. This development eliminates the need to transfer finished products to another supplier for development and coating application services.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.